EyePoint Pharmaceuticals DSO Ratio 2011-2026 | EYPT

Annual DSO Ratio EyePoint Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.32	5.95	64.7	149	137	100	204	43.5	12.2	110	8.55	54.3	102	100	62

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
204	5.95	77.4

Quarterly DSO Ratio EyePoint Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
78.9	9.13	1.96	-	7.6	-	-	-	34.3	107	154	-	95.1	77.3	186	-	145	139	136	-	55	209	127	120	413	144	272	23.4	118	80	45	28.1	63.8	17.4	54.8	7.02	156	7.46	175	99.1	117	108	132	2.29 K	46.8	90.5	2.08	135	131	92	118	147	157	151	164	126	43.1	122	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.29 K	1.96	148

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	3.22 %	$ 9.26 B	Australia
Alnylam Pharmaceuticals ALNY	58.1	$ 330.55	-0.85 %	$ 43.3 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 21.68	-	$ 1.01 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.17	-2.16 %	$ 5.22 M	Israel
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.5	-3.23 %	$ 386 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	103	$ 4.24	-0.12 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.54	-0.18 %	$ 3.12 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	-1.01 %	$ 394 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	321	$ 33.97	0.3 %	$ 2.26 B	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA